Sneha Khedkar is a freelance science journalist based out of Bengaluru, India. She writes about health and life sciences. Her work has appeared in Scientific American, Knowable Magazine, New Scientist and The Scientist, among other publications. She completed an M.Sc. in biochemistry at the Maharaja Sayajirao University of Baroda, after which she was a research fellow studying stem cells in the skin. Her website is https://www.snehakhedkar.com/.
Sneha Khedkar
Contributing writer
From this contributor
Egyptian fruit bats’ neural patterns represent different experimenters
The findings underscore the importance of accounting for “experimenter effects” on lab animals.
Egyptian fruit bats’ neural patterns represent different experimenters
By
Sneha Khedkar
13 August 2024 | 4 min read
Explore more from The Transmitter
Supported by a $40 million NIH grant, Yale brain shuttle technology raises questions
Yale University claims its STEP platform might be able to deliver gene-editing tools into the brain via multiple routes. Researchers are eager to see more.
Supported by a $40 million NIH grant, Yale brain shuttle technology raises questions
Yale University claims its STEP platform might be able to deliver gene-editing tools into the brain via multiple routes. Researchers are eager to see more.
By
Natalia Mesa
3 June 2026 | 11 min read
What counts as a ‘naturalistic’ behavior?
Nedah Nemati explains how neuroscience methods and the lived experience of the scientists themselves shape how we define the behaviors we seek to explain.
What counts as a ‘naturalistic’ behavior?
Nedah Nemati explains how neuroscience methods and the lived experience of the scientists themselves shape how we define the behaviors we seek to explain.
By
Paul Middlebrooks
3 June 2026 | 1 min read
Allen Institute sets sights on treatments for five brain diseases
The Brain Health Accelerator program aims to harness single-cell transcriptomics and cell-type-specific genetic tools to develop treatments for Alzheimer’s, Huntington’s and Parkinson’s diseases, Lewy body dementia and ALS.
Allen Institute sets sights on treatments for five brain diseases
The Brain Health Accelerator program aims to harness single-cell transcriptomics and cell-type-specific genetic tools to develop treatments for Alzheimer’s, Huntington’s and Parkinson’s diseases, Lewy body dementia and ALS.
By
Calli McMurray
2 June 2026 | 5 min read